HomeXBRANE • STO
add
Xbrane Biopharma AB
Previous close
kr 0.25
Day range
kr 0.24 - kr 0.25
Year range
kr 0.13 - kr 0.31
Market cap
621.67M SEK
Avg Volume
14.54M
P/E ratio
4.80
Dividend yield
-
Primary exchange
STO
Market news
Financials
Income Statement
Revenue
Net income
| (SEK) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | 39.91M | -23.30% |
Operating expense | 41.52M | -39.03% |
Net income | 169.59M | 340.54% |
Net profit margin | 424.92 | 413.62% |
Earnings per share | -0.00 | 90.85% |
EBITDA | 2.52M | 7.73% |
Effective tax rate | -16.80% | — |
Balance Sheet
Total assets
Total liabilities
| (SEK) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 5.86M | -91.95% |
Total assets | 601.79M | -28.12% |
Total liabilities | 216.90M | -59.28% |
Total equity | 384.89M | — |
Shares outstanding | 1.53B | — |
Price to book | 0.98 | — |
Return on assets | -0.62% | — |
Return on capital | -1.04% | — |
Cash Flow
Net change in cash
| (SEK) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | 169.59M | 340.54% |
Cash from operations | -65.06M | 34.64% |
Cash from investing | 48.57M | 560.48% |
Cash from financing | -1.08M | 98.74% |
Net change in cash | -18.85M | 90.43% |
Free cash flow | -64.94M | -19.21% |
About
CEO
Founded
2008
Website
Employees
26
